{"schema_version":"secwatch.filing_event.v1","accession":"0001638833-23-000002","form_type":"8-K","ticker":"SGRY","cik":"0001638833","company_name":"Surgery Partners, Inc.","filed_at":"2023-01-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.955620+00:00","generated_at":"2026-06-20T17:53:54.250591+00:00","sec_items":["2.02"],"event_type":"other","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Surgery Partners reaffirms 2022 revenue and Adj. EBITDA guidance at J.P. Morgan conference","bullets":["Reaffirms 2022 revenue guidance of $2.50B to $2.55B.","Reaffirms 2022 Adjusted EBITDA guidance of $375M to $385M.","Guidance based on results through November 2022; year-end adjustments pending.","Management presenting at 41st Annual J.P. Morgan Healthcare Conference on Jan 9, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001638833-23-000002","json":"https://secwatch.observer/filing/0001638833-23-000002.json","markdown":"https://secwatch.observer/filing/0001638833-23-000002.md","text":"https://secwatch.observer/filing/0001638833-23-000002.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1638833/000163883323000002/0001638833-23-000002-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1638833/000163883323000002/sgry-20230109.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T17:53:54.250591+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1866275a00ced8cba7ea5a9b84361396a4166454","claim":"Surgery Partners, Inc. reported the fiscal year ended December 31, 2022 results: revenue $2.50 billion to $2.55 billion. Guidance reaffirmed.","evidence_excerpt":"Based on results through November 2022, the Company is re-affirming its 2022 Adjusted EBITDA guidance of $375 million to $385 million and its 2022 Revenue guidance of $2.50 billion to $2.55 billion.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1638833/000163883323000002/0001638833-23-000002-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fiscal year ended December 31, 2022"},{"label":"Revenue","value":"$2.50 billion to $2.55 billion"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}